Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 175   

Articles published

GSK 1,428.85 +5.85 (0.41%)
price chart
Neil Woodford Still Loves Astrazeneca plc And GlaxoSmithKline plc
AstraZeneca Loyalty is a wonderful thing, and Neil Woodford has bags of it. He has just announced the top 10 holdings in his new CF Woodford Equity Income fund, and the only surprise is how few surprises there are.
Ex-Invesco star Woodford's start-up bets on tobacco, drug firms  Reuters UK
Woodford's Cautious Stance See Glaxo, BAT Top 10 Holdings  Businessweek
Related articles »  
GlaxoSmithKline plc Price Target Cut to GBX 1500 (GSK)
GlaxoSmithKline plc logo Equities researchers at Deutsche Bank cut their price target on shares of GlaxoSmithKline plc (LON:GSK) from GBX 1,630 ($27.85) to GBX 1,500 ($25.63) in a research report issued on Thursday. The firm currently has a �hold ...
Related articles »  
Why GlaxoSmithKline (GSK) Stock Continues To Sink Today
"We rate GLAXOSMITHKLINE PLC (GSK) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate.
Related articles »  
GlaxoSmithKline plc Stock Rating Reaffirmed by Credit Suisse (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its �underperform� rating reiterated by equities researchers at Credit Suisse in a research report issued on Friday.
Related articles »  
Should You Invest In Shire PLC Instead Of GlaxoSmithKline plc And ...
Meanwhile, stable mate GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) continues to deal with negative publicity surrounding its Chinese operations, thereby holding its share price back throughout 2014 so that it is now down 1% for the year.
Related articles »  
GlaxoSmithKline plc (ADR) (GSK) Announces Quarterly Dividend of $0.65
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) declared a quarterly dividend on Thursday, July 24th, American Banking News.
GlaxoSmithKline plc Rating Reiterated by Barclays (GSK)
GlaxoSmithKline plc (NYSE:GSK)'s stock had its �equal weight� rating reaffirmed by research analysts at Barclays in a report released on Thursday.
Add Syria To The List: Whistleblower Alleges GSK Corruption
GlaxoSmithKline plc (ADR) (GSK) was again accused for corruption, this time in Syria, after a series of claims in countries from China to Poland had surfaced in the last little while.
GlaxoSmithKline plc Rating Reiterated by Jefferies Group (GSK)
GlaxoSmithKline plc (LON:GSK)'s stock had its �hold� rating reiterated by stock analysts at Jefferies Group in a report issued on Friday.
GSK Tumbles On Earnings Miss, Lowered EPS Guidance
GlaxoSmithKline plc (ADR) (GSK) reported results for the second quarter of its 2014 fiscal year (2QFY14) today, causing the stock to decline in pre-market trading.